title: Effects of dehydroepiandrosterone supplementation on cognitive function and quality of life: the DHEA and Well-Ness (DAWN) Trial.
abstract: OBJECTIVE
  To examine the effects of dehydroepiandrosterone (DHEA) supplementation on cognitive function and quality of life in healthy older adults.
  
  
  METHODS
  Double-blind, randomized, controlled clinical trial.
  
  
  METHODS
  Clinical research facility.
  
  
  METHODS
  One hundred ten men and 115 women aged 55 to 85 (mean +/- standard deviation 68 +/- 8).
  
  
  METHODS
  Fifty milligrams daily oral DHEA versus placebo for 1 year.
  
  
  METHODS
  Six cognitive function tests at baseline and 12 months, the Beck Depression Inventory (BDI), the Medical Outcomes Study 36-item Short Form Survey (SF-36), the Life Satisfaction Index-Z, the Satisfaction with Life Scale, the Female Sexual Function Index (in women), and the 15-item International Index of Erectile Function (in men) at baseline and 3, 6, and 12 months.
  
  
  RESULTS
  There were no differences between the DHEA and placebo groups in change over time in cognitive function (P>.10). Over time, BDI scores decreased for men (P=.006) and women (P=.02), and Satisfaction with Life Scale scores increased for women (P=.004), but there were no differences between the DHEA and placebo groups over time on these measures or the SF-36, Life Satisfaction Index-Z scale, or sexual function scales (P>.10).
  
  
  CONCLUSIONS
  DHEA supplementation has no benefit on cognitive performance or well-being in healthy older adults, and it should not be recommended for that purpose in the general population.
authors.affiliation: Department of Family & Preventive Medicine, School of Medicine, University of California at San Diego, La Jolla, California 92093-0631, USA. dsilverstein@ucsd.edu
authors.forename: Donna
authors.initials: D
authors.lastname: Kritz-Silverstein
authors.forename: Denise
authors.initials: D
authors.lastname: von Mühlen
authors.forename: Gail A
authors.initials: GA
authors.lastname: Laughlin
authors.forename: Ricki
authors.initials: R
authors.lastname: Bettencourt
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000284:Administration, Oral; D000368:Aged; D000369:Aged, 80 and over; D003071:Cognition / Q000187:drug effects*; D003687:Dehydroepiandrosterone / Q000494:pharmacology*; D019587:Dietary Supplements; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007989:Libido / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D011788:Quality of Life
chemical_list: D000276:Adjuvants, Immunologic; D003687:Dehydroepiandrosterone